Viewing Study NCT01207102


Ignite Creation Date: 2025-12-25 @ 4:04 AM
Ignite Modification Date: 2026-05-13 @ 9:08 PM
Study NCT ID: NCT01207102
Status: TERMINATED
Last Update Posted: 2014-12-15
First Post: 2010-09-10
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Study Of Abraxane® And Carboplatin As First-Line Treatment For Triple Negative Metastatic Breast Cancer
Sponsor:
Organization: